Lactose India [LACTOSE] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Lactose India

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Lactose India wins in 11 metrics, Suven Life Sciences wins in 7 metrics, with 0 ties. Lactose India appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricLactose IndiaSuven Life SciencesBetter
P/E Ratio (TTM)37.76-28.31Suven Life Sciences
Price-to-Book Ratio2.7741.36Lactose India
Debt-to-Equity Ratio96.750.00Suven Life Sciences
PEG Ratio-1.11-0.34Lactose India
EV/EBITDA13.07-24.12Suven Life Sciences
Profit Margin (TTM)3.47%84.44%Suven Life Sciences
Operating Margin (TTM)7.82%-2,791.92%Lactose India
EBITDA Margin (TTM)7.82%N/AN/A
Return on Equity8.79%-146.15%Lactose India
Return on Assets (TTM)3.87%-118.91%Lactose India
Free Cash Flow (TTM)$-146.70M$-1.91BLactose India
1-Year Return-19.88%49.21%Suven Life Sciences
Price-to-Sales Ratio (TTM)1.29632.35Lactose India
Enterprise Value$2.09B$44.90BSuven Life Sciences
EV/Revenue Ratio1.65597.31Lactose India
Gross Profit Margin (TTM)25.58%100.00%Suven Life Sciences
Revenue per Share (TTM)$101$0Lactose India
Earnings per Share (Diluted)$3.42$-8.45Lactose India
Beta (Stock Volatility)0.450.78Lactose India
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Lactose India vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Lactose India
Suven Life Sciences
Lactose India Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lactose India-2.56%3.14%-3.66%24.90%21.26%-43.61%
Suven Life Sciences-2.18%3.79%-10.27%-21.82%76.25%63.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lactose India-19.88%89.53%630.41%177.25%880.38%21,069.49%
Suven Life Sciences49.21%215.69%329.98%-26.12%600.33%3,806.72%

News Based Sentiment: Lactose India vs Suven Life Sciences

Lactose India

News based Sentiment: MIXED

October presented a mixed bag for Lactose India Ltd., with a strong stock surge early in the month followed by a price decline, coupled with positive revenue growth but a year-over-year decrease in net profit. This combination of positive and negative developments creates a complex investment narrative.

View Lactose India News Sentiment Analysis

Suven Life Sciences

News based Sentiment: MIXED

October was a month of conflicting signals for Suven Life Sciences. While the company benefited from a positive pharmaceutical sector rally and maintained a debt-free status, it also reported continued quarterly losses and received a negative analyst rating. This creates a complex investment narrative with both potential opportunities and significant risks.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Lactose India vs Suven Life Sciences

MetricLACTOSESUVEN
Market Information
Market Cap i₹1.59B₹47.99B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i9,454184,111
90 Day Avg. Volume i12,647150,383
Last Close₹121.70₹204.83
52 Week Range₹84.27 - ₹231.00₹102.50 - ₹299.99
% from 52W High-47.32%-31.72%
All-Time High₹247.40 (Dec 09, 2024)₹338.50 (Apr 13, 2015)
% from All-Time High-50.81%-39.49%
Growth Metrics
Quarterly Revenue Growth0.34%0.86%
Quarterly Earnings Growth-0.34%0.86%
Financial Health
Profit Margin (TTM) i0.03%0.84%
Operating Margin (TTM) i0.08%-27.92%
Return on Equity (TTM) i0.09%-1.46%
Debt to Equity (MRQ) i96.750.00
Cash & Liquidity
Book Value per Share (MRQ)₹46.65₹5.04
Cash per Share (MRQ)₹3.92₹2.75
Operating Cash Flow (TTM) i₹-49,118,000₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹51.63M₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Lactose India vs Suven Life Sciences

MetricLACTOSESUVEN
Price Ratios
P/E Ratio (TTM) i37.76-28.31
Forward P/E iN/A10.78
PEG Ratio i-1.11-0.34
Price to Sales (TTM) i1.29632.35
Price to Book (MRQ) i2.7741.36
Market Capitalization
Market Capitalization i₹1.59B₹47.99B
Enterprise Value i₹2.09B₹44.90B
Enterprise Value Metrics
Enterprise to Revenue i1.65597.31
Enterprise to EBITDA i13.07-24.12
Risk & Other Metrics
Beta i0.450.78
Book Value per Share (MRQ) i₹46.65₹5.04

Financial Statements Comparison: Lactose India vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)LACTOSESUVEN
Revenue/Sales i₹395.76M₹18.67M
Cost of Goods Sold i₹294.50M₹0
Gross Profit i₹101.25M₹18.67M
Research & Development iN/A₹414.88M
Operating Income (EBIT) i₹30.94M₹-521.17M
EBITDA i₹48.82M₹-501.49M
Pre-Tax Income i₹22.89M₹-515.17M
Income Tax i₹7.90M₹0
Net Income (Profit) i₹14.99M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)LACTOSESUVEN
Cash & Equivalents i₹44.81M₹150.26M
Total Current Assets i₹573.26M₹754.72M
Total Current Liabilities i₹448.90M₹234.86M
Long-Term Debt i₹259.33MN/A
Total Shareholders Equity i₹587.40M₹1.10B
Retained Earnings i₹260.03M₹-6.01B
Property, Plant & Equipment i₹12.74M₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)LACTOSESUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLACTOSESUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i9,454184,111
Average Daily Volume (90 Day) i12,647150,383
Shares Outstanding i12.59M218.07M
Float Shares i5.03M67.61M
% Held by Insiders i0.59%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Lactose India vs Suven Life Sciences

MetricLACTOSESUVEN
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A